Triamcinolone acetonide for the treatment of allergic rhinitis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 30, 1988
Grant Date -
N/A
app pub date -
Jan 23, 1987
filing date -
Jan 23, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed is a method for the treatment of allergic rhinitis that manifests itself as rhinorrhea, nasal itching, sneezing, congestion and postnasal drip. The method comprises the administration from a nasal aerosol dispenser an effective amount of micronized triamcinolone acetonide suspended in dichlorodifluoromethane into the nasal cavity of a patient suffering from allergic rhinitis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully